SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalAMDL Inc.


Next 10 
To: Stock Puppy who wrote ()6/15/1996 9:04:00 PM
From: Chris Forte
   of 28
 
Mr. Puppy<g>, I was glad, almost startled to see your post on AMDL.
I was starting to feel a little lonely. As far as I can tell, AMDD is flying under the radar screen of most so far.
We've started a discussion of AMDL over on the MICROCAPitalist board on Prodigy. I think I have a semi-decent handle on the story, but I'm still trying to learn more by opening up discussion. So far I think there is potential here. I've talked to as many people I can about AMDD, including the President, CEO Dr. Ngo.
Mike Harrison's Small Wonders web site has a write up of AMDL Inc at tiac.net
Also the company's phone is 714-505-4460 and their IR is via Versaggi Biocommunications at 414-547-1320(ask for Venessa de Harven).
Overall I'm hoping to hear what others think. Like any investment, there are many unanswered questions here, but also some interesting potential. How do you see it so far? Thanks Chris

Share RecommendKeepReplyMark as Last Read


To: Chris Forte who wrote (1)6/17/1996 10:17:00 AM
From: Stock Puppy
   of 28
 
It is interesting, and I am still looking into it.
I've thought of just diving in with a small initial
holding, but what really gives me pause (ouch) is that
the stock price chart looks horrible.

Share RecommendKeepReplyMark as Last Read


To: Stock Puppy who wrote (2)6/18/1996 8:36:00 AM
From: Chris Forte
   of 28
 
Mr. Puppy, (or can I call you Stock?), I'm not much of a chart reader, so I'd be interested in your insight. For what it's worth, the volume over the last few days has been good. I didn't check the close yesterday(monday) but I think it was over 180,000v - not bad.
I'm more of a fundamentals guy, and that's why I'm interested. This product may find a nice niche, and things are really starting to unfold. I expect the next six months to be very interesting, news-wise. It's definitely worth doing homework on. Good luck. Chris

Share RecommendKeepReplyMark as Last Read


To: Chris Forte who wrote (3)6/18/1996 9:42:00 AM
From: Stock Puppy
   of 28
 
My insight isn't all that deep, since I'm
still learning this financial stuff.

Looking at the chart (which only goes back about a year) makes me wonder why the stock price dropped from $2 last year to .50 and it seems like the trend, except for this month, is mostly down, which is why I didn't like it. (It's bouncing down except on the last bounce, it hit a firecracker which shot it up a bit).

I do have a good feeling about this stock though, and you're right, recent volume looks good, the recommendation by Small Wonders makes it more positive. My interest is finding out more about their product.

Share RecommendKeepReplyMark as Last Read


To: Stock Puppy who wrote (4)6/19/1996 8:31:00 AM
From: Chris Forte
   of 28
 
Yes, I agree, finding out about the product is important. Without stating the obvious, if the product is in demand, everything will take care of itself.
One thing to remember about AMDD - they make diagnostic TESTS, not drugs or invasive procedures which have SIDE EFFECTS. Tests are approved much more quickly than drugs etc which can take years of clinical trials to prove their efficacy and safety.
AMDL Inc has lined up many distributors around the world, they are just waiting for approvals. Its already been approved in Canada, so that will help. China and Indonesia IMHO are most likely to step up to the plate first in the near future. These are all multimillion dollar escalating agreements. There are still more distributor announcements to come, again IMHO.
I like the fact that a stream of news should help AMDL over the next 6 months. From what I can tell the product, DR-70 could find a very nice niche. It's not perfect, but nothing in medicine is.
By the way, the 400,000 volume yesterday was interesting, no?
Chris

Share RecommendKeepReplyMark as Last Read


To: Chris Forte who wrote (5)6/19/1996 9:28:00 AM
From: paul lin
   of 28
 
Chris, very interesting situation here indeed. But I am just wondering if their test kits have the technical edge vs. others (as I recall, their DR-70 has specificity over 90% and sensitivity only 60%). Any strong competition you can see? Thank you for your comment.

PL

Share RecommendKeepReplyMark as Last Read


To: Chris Forte who wrote (5)6/19/1996 12:18:00 PM
From: Stock Puppy
   of 28
 
Looks like the roller coaster is starting. Up to 1.5 today!
I made the purely emotional decision to buy a small position yesterday...Glad I did...ISSM is really nose diving...OCGT is drifting down...Coulda bought more AMDD...my eyes hurt...(complain, complain :-))

To be determined about the product: what is their competition, what are other methods of doing this test, problems & costs involved, % false negatives, false positives, references...

Of course, we could buy on news and sell on rumor (or is it the other way around:-)

Share RecommendKeepReplyMark as Last Read


To: Stock Puppy who wrote (7)6/19/1996 1:41:00 PM
From: Eduardo Canto
   of 28
 
Mr. Puppy,

Called the company, I am told that the activity might be due to some good reviews that have and are comming out. I asked about their present direction and was told that they are working on a H. Pylori test (the bacteria that cause ulcers). They seem to be making good progress on their lung cancer test world marketing. I am also long on this one...

E.C.

Share RecommendKeepReplyMark as Last Read


To: paul lin who wrote (6)6/19/1996 2:31:00 PM
From: Chris Forte
   of 28
 
Paul, the as far as I know, the DR-70 test has little competition in lung cancer. In other cancers it may bump up against other markers. Clinical trials in Germany are wrapping up now which was designed to test DR-70's effectiveness in diagnosing other cancers, which would give it some kind of ranking so to speak against other markers.
Your question is a good one - it's probably the whole key to this product - is it good enough for a doctor in the field to order it? I was initially concerned about the sensitivity also, but at the risk of sounding like a spin doctor(pardon the pun), it has to be taken in relation to what else is out there. Tests of this nature aren't 100%. Almost nothing is. Is it good enough to be clinically useful? In my opinion it is based on conversations I've
had with people a lot smarter than I am about these tests.
Remember also, one of the strong selling points of DR-70 is its ability to diagnose many types of cancer, and to act as a screening test for pre or post diagnostic uses. Will it be a "pan" tumor marker for all cancers? No. But is it a useful product for a clinician in multiple markets? I believe and hope so. Only time will tell. That's what's exciting to me... the time is coming soon. Chris

Share RecommendKeepReplyMark as Last Read


To: Stock Puppy who wrote (7)6/19/1996 2:38:00 PM
From: Chris Forte
   of 28
 
Yes, another pretty wild ride to say the least! At one point it was up .563 1.656 x 1.75 on 300,000volume. Not bad! Don't know if it will hold, but the point is, somebody out there noticed little AMDL Inc. Looks like you made a good decision. Lets hope we have a long and successful ride. Chris

Share RecommendKeepReplyMark as Last Read
Next 10